Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: It takes two to tango.

Koutsilieri S, Caudle KE, Alzghari SK, Monte AA, Relling MV, Patrinos GP.

Am J Hematol. 2019 Apr 3. doi: 10.1002/ajh.25485. [Epub ahead of print] No abstract available.

PMID:
30945335
2.

Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study.

Monte AA, Shelton SK, Mills E, Saben J, Hopkinson A, Sonn B, Devivo M, Chang T, Fox J, Brevik C, Williamson K, Abbott D.

Ann Intern Med. 2019 Mar 26. doi: 10.7326/M18-2809. [Epub ahead of print]

PMID:
30909297
3.

Response to "Methodological Considerations on CYP2D6 Phenoconversion Due to Drug-Drug Interaction".

West K, Monte AA.

Clin Pharmacol Ther. 2019 May;105(5):1077-1078. doi: 10.1002/cpt.1333. Epub 2019 Feb 10. No abstract available.

PMID:
30739321
4.

Brief Commentary: Consequences of Marijuana: Observations From the Emergency Department.

Heard K, Monte AA, Hoyte CO.

Ann Intern Med. 2019 Jan 8. doi: 10.7326/M18-3280. [Epub ahead of print] No abstract available.

PMID:
30615784
5.

Deaths in Colorado Attributed to Kratom.

Gershman K, Timm K, Frank M, Lampi L, Melamed J, Gerona R, Monte AA.

N Engl J Med. 2019 Jan 3;380(1):97-98. doi: 10.1056/NEJMc1811055. No abstract available.

PMID:
30601742
6.

Risk of Fluid Overload From Failure to Concentrate High-Dose Insulin as an Intravenous Antidote.

Schimmel J, Monte AA.

Ann Pharmacother. 2019 Mar;53(3):325. doi: 10.1177/1060028018810794. Epub 2018 Oct 31. No abstract available.

PMID:
30378442
7.

The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care.

Saben JL, Shelton SK, Hopkinson AJ, Sonn BJ, Mills EB, Welham M, Westmoreland M, Zane R, Ginde AA, Bookman K, Oeth J, Chavez M, DeVivo M, Lakin A, Heldens J, Romero LB, Ames MJ, Roberts ER, Taylor M, Crooks K, Wicks SJ, Barnes KC, Monte AA.

Acad Emerg Med. 2018 Sep 21. doi: 10.1111/acem.13620. [Epub ahead of print]

PMID:
30239069
8.

Priorities to Overcome Barriers Impacting Data Science Application in Emergency Care Research.

Puskarich MA, Callaway C, Silbergleit R, Pines JM, Obermeyer Z, Wright DW, Hsia RY, Shah MN, Monte AA, Limkakeng AT Jr, Meisel ZF, Levy PD.

Acad Emerg Med. 2019 Jan;26(1):97-105. doi: 10.1111/acem.13520. Epub 2018 Aug 16.

PMID:
30019795
9.

CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction.

Monte AA, West K, McDaniel KT, Flaten HK, Saben J, Shelton S, Abdelmawla F, Bushman LR, Williamson K, Abbott D, Anderson PL.

Clin Pharmacol Ther. 2018 Nov;104(5):933-939. doi: 10.1002/cpt.1135. Epub 2018 Jul 25.

10.

Introduction to the Specific Aims Page of a Grant Proposal.

Monte AA, Libby AM.

Acad Emerg Med. 2018 Sep;25(9):1042-1047. doi: 10.1111/acem.13419. Epub 2018 May 7.

PMID:
29608233
11.

Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado.

Hall KE, Monte AA, Chang T, Fox J, Brevik C, Vigil DI, Van Dyke M, James KA.

Acad Emerg Med. 2018 May;25(5):526-537. doi: 10.1111/acem.13393. Epub 2018 Apr 10.

12.

Drugs of Abuse and Novel Psychoactive Substances at Outdoor Music Festivals in Colorado.

Fox J, Smith A, Yale A, Chow C, Alaswad E, Cushing T, Monte AA.

Subst Use Misuse. 2018 Jun 7;53(7):1203-1211. doi: 10.1080/10826084.2017.1400067. Epub 2017 Nov 17.

13.

Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.

Brandehoff N, Adams A, McDaniel K, Banister SD, Gerona R, Monte AA.

Clin Toxicol (Phila). 2018 Mar;56(3):193-198. doi: 10.1080/15563650.2017.1357826. Epub 2017 Sep 1.

14.

The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.

Flaten HK, Monte AA.

Cardiovasc Drugs Ther. 2017 Aug;31(4):471-482. doi: 10.1007/s10557-017-6733-2. Review.

15.

The Plasma Concentration of MUC5B Is Associated with Clinical Outcomes in Paraquat-poisoned Patients.

Monte AA, Sun H, Rapp-Olsson AM, Mohamed F, Gawarammana I, Buckley NA, Evans CM, Yang IV, Schwartz DA.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):663-665. doi: 10.1164/rccm.201705-0866LE. No abstract available. Erratum in: Am J Respir Crit Care Med. 2018 Apr 15;197(8):1093.

16.

Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.

Monte AA, Calello DP, Gerona RR, Hamad E, Campleman SL, Brent J, Wax P, Carlson RG; ACMT Toxicology Investigators Consortium (ToxIC).

J Med Toxicol. 2017 Jun;13(2):146-152. doi: 10.1007/s13181-017-0605-9. Epub 2017 Apr 10.

17.

In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use".

Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA.

J Med Toxicol. 2017 Jun;13(2):201. doi: 10.1007/s13181-017-0613-9. Epub 2017 Apr 5. No abstract available.

18.

Marijuana and acute health care contacts in Colorado.

Wang GS, Hall K, Vigil D, Banerji S, Monte A, VanDyke M.

Prev Med. 2017 Nov;104:24-30. doi: 10.1016/j.ypmed.2017.03.022. Epub 2017 Mar 30.

19.

In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA.

J Med Toxicol. 2017 Jun;13(2):198. doi: 10.1007/s13181-017-0610-z. Epub 2017 Mar 10. No abstract available.

20.

Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA.

J Med Toxicol. 2017 Mar;13(1):71-87. doi: 10.1007/s13181-016-0595-z. Epub 2016 Dec 20. Review.

Supplemental Content

Loading ...
Support Center